leap-004: initial results
Published 4 years ago • 107 plays • Length 6:00Download video MP4
Download video MP3
Similar videos
-
6:05
leap-004: lenvatinib pembrolizumab for patients with advanced melanoma and confirmed progressi...
-
1:25
ana maria arance fernandez, md, phd, regrading the leap-004 clinical trial presented at esmo 2020
-
0:56
treating patients with melanoma who progressed on anti-pd-l1 with lenvatinib and pembrolizumab
-
2:21
lba41 - leap-005: phase ii study of lenvatinib plus pembrolizumab
-
1:32
clinical trial: lenvatinib for uveal melanoma (nct05308901)
-
5:32
melanoma matters: melanoma and life expectancy (julie's story)
-
12:59
treatment plan for my stage 4 melanoma recurrence
-
8:46
today immunotherapy can cure even fourth stage cancer: dr dattatreyudu nori
-
2:41
leap-011: exploring first-line pembrolizumab lenvatinib for advanced urothelial carcinoma
-
1:08
keynote-716: safety profile and results of pembrolizumab for melanoma
-
1:14
exploring treatment options after til therapy in melanoma: biomarkers & regimen selection
-
1:05
3-year update from the keynote-942 trial: mrna-4157 (v940) pembrolizumab in resected melanoma
-
1:42
improving responses to immunotherapy for patients with endometrial cancer
-
0:37
tils prolong pfs compared with pembrolizumab in advanced melanoma
-
1:39
advanced melanoma trial when keytruda alone is not enough
-
2:26
updating the treatment algorithm for metastatic melanoma
-
5:44
4-year results from checkmate 238: adjuvant nivo vs ipi in resected stage iii/iv melanoma
-
9:07
optimal treatment of metastatic melanoma at progression
-
6:02
melanoma: progression after immunotherapy
-
2:39
updated video available: justine's story - brain metastatic melanoma at pacific brain tumor center
-
1:12
current trials in the treatment of melanoma
-
8:35
long-term results for immunotherapy in melanoma